이성우 (전남대학교 의과대학)님 | 한빛사연구자 > 한빛사

전남대학교 의과대학

최종업데이트 2025.06.20.

Progressive accumulation of circulating CD27-CD28- effector/memory CD8+ T cells in patients with lung cancer blunts responses to immune checkpoint inhibitor therapy
- Exp. Mol. Med., May 01 2025, | https://doi.org/10.1038/s12276-025-01448-7
- 2025-05
- 의약학
- 한빛사논문
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer
- J. Immunother. Cancer, 26 February 2025 | https://doi.org/10.1136/jitc-2024-010193
- 2025-02
- 생명과학
- 한빛사논문
[Letter] Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti-PD-1 therapy
- Cancer Commun., Nov 20 2024, | https://doi.org/10.1002/cac2.12631
- 2024-11
- 한빛사논문
Self-reactivity controls functional diversity of naive CD8+ T cells by co-opting tonic type I interferon
- Nat. Commun., Published 18 October 2021 | https://doi.org/10.1038/s41467-021-26351-3
- 2021-10
- 의약학
- 한빛사논문
CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens
- J. Immunother. Cancer, Online issue publication September 30, 2021 | doi: 10.1136/jitc-2021-002709
- 2021-09
- 의약학
- 한빛사논문

연구자 ID

저자논문